Portrait of Moore, Tim

Moore, Tim

U.S. Representative NC-14 Republican Party

Congressional stock trade history disclosed under the STOCK Act, parsed and scored by FilingIQ.

Disclosed trades
235
Buys / sells
74% / 26%
Last trade
Jun 4, 2026
Last filing
Jun 5, 2026

Latest disclosed trades

Latest 10 of 235
Ticker Type Traded
T Buy Jun 4, 2026
T Sell May 21, 2026
T Buy May 18, 2026
IHG Buy May 7, 2026
RYCEY Buy May 7, 2026
HOG Sell Apr 7, 2026
CBRL Sell Apr 1, 2026
LGIH Sell Mar 26, 2026
NVDA Sell Mar 24, 2026
CBRL Buy Mar 23, 2026

Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window, and to see the FilingIQ Score on every trade.

Moore, Tim stock trade activity

FilingIQ has indexed 235 congressional stock trade disclosures for Moore, Tim. The most recent disclosed transaction is dated Jun 4, 2026.

Across the full history, 174 purchases and 61 sales have been disclosed under the STOCK Act.

Top tickers traded by Moore, Tim

Frequently asked

How many stock trades has Moore, Tim disclosed?
FilingIQ tracks 235 Periodic Transaction Report disclosures for Moore, Tim, with the most recent dated Jun 4, 2026. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
Is Moore, Tim a net buyer or net seller?
Across the disclosed trade history, 174 (74%) were purchases and 61 (26%) were sales. Compensation and exchanges are filtered out of these counts.
Where does FilingIQ's data on Moore, Tim come from?
Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.

Methodology & sources

Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.